Sinobioway Group
Sinobioway Group focuses on establishing bioeconomy systems and developing bio-industries, with investments in biomedicine, bioagriculture, bioenergy, bioenvironment, bioservices, biomanufacturing, and biointelligence. As a leading enterprise in China's bioindustry, the company has the potential to become a globally competitive corporate group.
2 past transactions
Enerkem
Corporate Round in 2018
Enerkem transforms non-recyclable waste into renewable biofuels and chemicals. Its proprietary thermochemical process converts municipal solid waste into biofuels like ethanol, addressing oil dependence and waste disposal challenges.
EXUMA Biotech
Series A in 2017
EXUMA Biotech is a clinical-stage biotechnology company that develops CAR-T cell therapies for solid tumors. It focuses on enabling the immune system to attack solid malignancies, including renal cell carcinoma, soft tissue sarcoma, and gastric cancer. Founded in 2015, the company is based in Florida and maintains operations in California, the Cayman Islands, and China, with a strategic partnership with Shanghai PerHum Therapeutics Co., Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.